The role of β2-adrenergic receptor variation in human Hypertension

Current Hypertension Reports

Volumn 2, Issue 1, 2000, Pages 39-43

  Bray, Molly S ^a   Boerwinkle, Eric ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; LEPTIN;

ANIMAL; BLOOD; COMORBIDITY; GENETIC POLYMORPHISM; GENETICS; HUMAN; HYPERTENSION; MALE; MOUSE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; TRANSGENIC MOUSE;

ANIMALS; COMORBIDITY; HUMANS; HYPERTENSION; LEPTIN; MALE; MICE; MICE, TRANSGENIC; OBESITY; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0034137151     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-000-0056-5     Document Type: Article

References (42)

1. Williams R, Hunt S, Hopkins P, et al: Genetic basis of familial dyslipidemia and hypertension: 15 year results from Utah. Am J Hypertens 1993, 6:319S-327S.
2. Rice T, Vogler G, Perusse L, et al: Cardiovascular risk factors in a French Canadian population: resolution of genetic and familial environmental effects on blood pressure using twins, adoptees, and extensive information on environ mental correlates. Genet Epidemiol 1989, 6:571-588.
3. Perusse L, Rice T, Bouchard C, et al: Cardiovascular risk factors in a French Canadian population: resolution of genetic and familial environmental effects on blood pressure by using extensive information on environmental correlates. Am J Hum Genet 1989, 45:240-251.
4. Schwinn D, Caron M, Lefkowitz R: The beta-adrenergic receptor as a model for molecular structure function relationships in G protein coupled receptors. In The Heart and Cardiovascular System, edn. 2. Edited by Fozzard H, Habes E, Jennings R, Katz A, Morgan H. New York: Raven Press; 1992:1657-1684.
5. Dzimiri N: Regulation of β adrenoceptor signaling in cardiac function and disease. Pharmacol Rev 1999, 51:465-501.
6. Di Bona G: Sympathetic nervous system influences on the kidney: role in hypertension. Am J Hypertens 1989, 2:119s-124s.
7. Schluter K, Zhou X, Piper H: Induction of hypertrophic responsiveness to isoprenaline by TGF beta in adult rat cardiomyocytes. Am J Physiol 1995, 269:C1311-C1316.
8. Emorine L, Marullo S, Delavier-Klutchko C, et al.: Structure of the gene for human beta 2 adrenergic receptor: expression and promoter characterization. Proc Natl Acad Sci USA 1987, 84:6995-6999.
9. Kobilka B, Dixon R, Frielle T, et al: cDNA for the human β2 adrenergic receptor: a protein with multiple membrane spanning domains and encoded by a gene whose location is shared with that of the receptor for platelet derived growth factor. Proc Natl Acad Sci USA 1987, 84:46-50.
10. Reihsaus E, Innis M, MacIntyre N, Liggett S: Mutations in the gene encoding for the β2 adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993, 8:334-339.
11. Yamada K, Ishiyama-Shigemoto S, Ichikawa F, et al: Polymorphism in the 5́-leader cistron of the beta2 adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab 1999, 84:1754-1757.
12. Green S, Turki J, Innis M, Liggett S: Amino terminal polymorphisms of the human β2 adrenergic receptor impart distinct agonist promoted regulatory properties Biochem 1994, 33:9414-9419.
13. Green S, Cole G, Jacinto M, et al: A polymorphism of the human beta 2 adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 1993, 268:23116-23121.
14. Turki J, Lorenz J, Green S, et al: Myocardial signaling defects and impaired cardiac function of a human β2 adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci USA 1996, 93:10483-10488.
15. Turki J, Pak H, Green S, et al: Polymorphisms of the β2 adrenergic receptor in nocturnal and non nocturnal asthma: evidence that Gly 16 correlates with the nocturnal pheno type. J Clin Invest 1995, 95:1635-1641.
16. Martinez F, Graves P, Baldini M, et al.: Association between genetic polymorphisms of the beta2 adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997, 100:3184-3188.
17. Hall I, Wheatley A, Wilding P, Liggett S: Association of the Glu27 β2 adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 1995, 345:1213-1214.
18. Svetkey L, Timmons P, Emovon O, et al: Association of hypertension with β2 and a2c10-adrenergic receptor genotype Hypertension 1996, 27:1210-1215.
19. Svetkey L, Chen YT, McKeown S, et al: Preliminary evidence of linkage of salt sensitivity in black Americans at the β2 adrenergic receptor locus. Hypertension 1997, 29:918-922.
20. Kotanko P, Binder A, Tasker J, et al: Essential hypertension in African Caribbeans associates with a variant of the beta2 adrenoceptor. Hypertension 1997, 30:773-776.
21. Lang C, Stein M, Brown R, et al: Attenuation of isoproterenol mediated vasodilatation in blacks. N Engl J Med 1995, 333:155-160.
22. Gratze G, Fortin J, Labugger R, et al: β2 Adrenergic receptor variant affect resting blood pressure and agonist induced vasodilation in young adult caucasians. Hypertension 1999, 33:1425-1430.
23. Timmermann B, Mo R, Luft F, et al.: Beta 2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: the Bergen Blood Pressure Study. Kidney Int 1998, 53:1455-1460.
24. Krushkal J, Xiong M, Ferrell R, et al.: Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet 1998, 7:1379-1383.
25. Krushkal J, Ferrell R, Mockrin S, et al.: Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation 1999, 99:1407-1410
26. Bohm M, Flesch M, Schnabel P: Beta-adrenergic signal transduction in the failing and hypertrophied myocardium. J Mol Med 1997, 75:842-848.
27. Lind L, Andersson PE, Andren B, et al.: Left ventricular hypertrophy is associated with the insulin resistance metabolic syndrome. J Hypertens 1995, 13:433-438.
28. Liggett S, Wagoner L, Craft L, et al.: The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 1998, 102:1534-1539.
29. Mori Y, Kim-Motoyama H, Ito Y, et al: The Gln27Glu beta2 adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun 1999, 258:138-140.
30. Ishiyama-Shigemoto S, Yamada K, Yuan X, et al.: Association of polymorphisms in the beta2 adrenergic receptor gene with obesity, hypertriglyceridemia, and diabetes mellitus. Diabetologia 1999, 42:98-101
31. Meirhaeghe A, Helbecque N, Cottel D, Amouyel P: Beta2 adrenoceptor gene polymorphism, body weight, and physical activity [letter]. Lancet 1999, 353:896.
32. Hellstrom L, Large V, Reynisdottir S, et al: The different effects of a Gln27Glu beta 2 adrenoceptor gene polymorphism on obesity in males and in females. J Intern Med 1999, 245:253-259.
33. Large V, Hellstrom L, Reynisdottir S, et al: Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta 2 adreno ceptor function. J Clin Invest 1997, 100:3005-3013.
34. Lonnqvist F, Wahrenberg H, Hellstrom L, et al.: Lipolytic catecholamine resistance due to decreased beta2 adreno ceptor expression in fat cells. J Clin Invest 1992, 90:2175-2186.
35. Shek E, Brands M, Hall J: Chronic leptin infusion increases arterial pressure. Hypertension 1998, 31:409-414.
36. Leyva F, Godsland F, Ghatei M, et al: Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998, 18:928-933.
37. Stein C, Nelson R, Deegan R, et al: Forearm beta adrenergic receptor mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest 1995, 96:579-585.
38. Chruscinski A, Rohrer D, Schauble E, et al: Targeted disruption of the β2 adrenergic receptor gene. J Biol Chem 1999, 274:16694-16700.
39. Prichard B, Cruickshank J: Beta blockade in hypertension: past, present, and future. In Hypertension: Pathophysiology, Diagnosis, and Management. Edited by Laragh J, Brenner B. New York: Raven Press; 1995:2827-2859.
40. Liggett S: Polymorphisms of the β2 adrenergic receptor and asthma. Am J Respir Crit Care Med 1997, 156:S156-S162.
41. Dorn GN, Tepe N, Lorenz J, et al.: Low- and high-level transgenic expression of β2 adrenergic receptors differen tially affect cardiac hypertrophy and function in Gaq over expressing mice. Proc Natl Acad Sci USA 1999, 96:6400-6405.
42. Prichard B, Battersby L, Cruickshank J: Overdosage with beta-adrenergic blocking agents. Adverse Drug React Acute Poisoning Rev 1984, 3:91-111.